Comparative Quantitative Analysis of Cluster of Differentiation 45 Antigen Expression on Lymphocyte Subsets
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Since the recent introduction of radioimmunotherapy (RIT) using antibodies against cluster of differentiation (CD) 45 for the treatment of lymphoma, the clinical significance of the CD45 antigen has been increasing steadily. Here, we analyzed CD45 expression on lymphocyte subsets using flow cytometry in order to predict the susceptibility of normal lymphocytes to RIT. Methods: Peripheral blood specimens were collected from 14 healthy individuals aged 25-54 yr. The mean fluorescence intensity (MFI) of the cell surface antigens was measured using a FACSCanto II system (Becton Dickinson Bioscience, USA). MFI values were converted into antibody binding capacity values using a Quantum Simply Cellular microbead kit (Bangs Laboratories, Inc., USA). Results: Among the lymphocyte subsets, the expression of CD45 was the highest (725,368±42,763) on natural killer T (NKT) cells, 674,030±48,187 on cytotoxic/suppressor T cells, 588,750±48,090 on natural killer (NK) cells, 580,211±29,168 on helper T (Th) cells, and 499,436±21,737 on B cells. The Th cells and NK cells expressed a similar level of CD45 (P=0.502). Forward scatter was the highest in NKT cells (P<0.05), whereas side scatter differed significantly between each of the lymphocyte subsets (P<0.05). CD3 expression was highest in the Th and NKT cells. Conclusions: NKT cells express the highest levels of CD45 antigen. Therefore, this lymphocyte subset would be most profoundly affected by RIT or pretargeted RIT. The monitoring of this lymphocyte subset during and after RIT should prove helpful.
Abstract
Background: Since the recent introduction of radioimmunotherapy (RIT) using antibodies against cluster of differentiation (CD) 45 for the treatment of lymphoma, the clinical significance of the CD45 antigen has been increasing steadily. Here, we analyzed CD45 expression on lymphocyte subsets using flow cytometry in order to predict the susceptibility of normal lymphocytes to RIT. Methods: Peripheral blood specimens were collected from 14 healthy individuals aged 25-54 yr. The mean fluorescence intensity (MFI) of the cell surface antigens was measured using a FACSCanto II system (Becton Dickinson Bioscience, USA). MFI values were converted into antibody binding capacity values using a Quantum Simply Cellular microbead kit (Bangs Laboratories, Inc., USA). Results: Among the lymphocyte subsets, the expression of CD45 was the highest (725,368±42,763) on natural killer T (NKT) cells, 674,030±48,187 on cytotoxic/suppressor T cells, 588,750±48,090 on natural killer (NK) cells, 580,211±29,168 on helper T (Th) cells, and 499,436±21,737 on B cells. The Th cells and NK cells expressed a similar level of CD45 (P=0.502). Forward scatter was the highest in NKT cells (P<0.05), whereas side scatter differed significantly between each of the lymphocyte subsets (P<0.05). CD3 expression was highest in the Th and NKT cells. Conclusions: NKT cells express the highest levels of CD45 antigen. Therefore, this lymphocyte subset would be most profoundly affected by RIT or pretargeted RIT. The monitoring of this lymphocyte subset during and after RIT should prove helpful.
참고문헌 (22)
- Kee SJ, "Laboratory evaluation of the cellular immune system. In: The Korean society for laboratory medicine, ed. Laboratory medicine. 4th ed", pp.601~610 (2009), E public
- Abbas AK, "Cellular and molecular immunology. 6th updated ed", pp.137~152 (2010), Saunders
- Falahati R, "Selective regulation of TCR signaling pathways by the CD45 protein tyrosine phosphatase during thymocyte development", J Immunol, 181, pp.6082~6091 (2008)
- Elder ME, "Investigation of signal transduction defects In Manual of molecular and clinical laboratory immunology. 7th ed", pp.901~905 (2006), ASM Press
- Panchal RG, "Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis", J Biol Chem, 284, pp.12874~12885 (2009)
- Green DJ, "Pretargeted radioimmunotherapy for B-cell lymphomas", Clin Cancer Res, 13, pp.5598~5603 (2007)
- Lin Y, "A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies", Cancer Res, 66, pp.3884~3892 (2006)
- Pagel JM, "Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas", Blood, 101, pp.2340~2348 (2003)
- Green DJ, "Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates", Blood, 114, pp.1226~1235 (2009)
- Broome HE, "Morphology of lymphocytes and plasma cells In Williams hematology. 7th ed", pp.1023~1030 (2006), McGraw-Hill
- Trinchieri G, "Functions of natural killer cells In Williams hematology. 7th ed", pp.1077~1082 (2006), McGraw-Hill
- Thompson CB, "Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA", J Immunol, 133, pp.2333~2342 (1984)
- Iritani BM, "c-Myc enhances protein synthesis and cell size during B lymphocyte development", Proc Natl Acad Sci USA, pp.13180~13185 (1999)
- Perillo NL, "In vitro cellular aging in T-lymphocyte cultures: analysis of DNA content and cell size", Exp Cell Res, 207, pp.131~135 (1993)
- Press OW, "Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies", Cancer Res, 49, pp.4906~4912 (1989)
- Carulli G, "CD45 expression in low-grade B-cell non-Hodgkin’s lymphomas", Leuk Res, 32, pp.263~267 (2008)
- Ratei R, "Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias", Cytometry B Clin Cytom, 70, pp.1~9 (2006)
- Bikoue A, "Quantitative analysis of leukocyte membrane antigen expression: normal adult values", Cytometry, 26, pp.137~147 (1996)
- Beverley P, "The importance of T3 in the activation of T lymphocytes", Nature, 304, pp.398~399 (1983)
- Lenkei R, "Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors", J Immunol Methods, 183, pp.267~277 (1995)
- Ginaldi L, "Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry", J Clin Pathol, 49, pp.539~544 (1996)
- Islam D, "Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry", Cytometry, 22, pp.128~134 (1995)
